Abstract:BACKGROUND & OBJECTIVE:Staphylococcal enterotoxin A (SEA) is one of the widely researched superantigens, which is prospective in antitumor therapy. However, its application is limited due to the toxicity. This study was conducted to prepare the nanoparticle-encapsulated SEA (NSEA) and to observe its influences on the T-cell subgroups and the antitumor effects in vivo. METHODS:NSEA was prepared by the interfacial polymerization method.BALB/c mice were divided into 3 groups (each group had 12 mice). After injection of 0.1 ml normal saline (NS I group), 0.1 ml 2 mg/L free SEA (SEA I group) and 0.1 ml 2 mg/L NSEA(NSEA I group), the changes of T-cell subgroups (CD4(+) and CD8(+)) were observed. The mice model bearing hepatocellular carcinoma H22 were injected with 0.1 ml NS(NS II group), 0.1 ml 2 mg/L free SEA(SEA II group), 0.1 ml 2 mg/L NSEA (NESA II group), then the tumor volume and the survival time were recorded. RESULTS:SEA and NSEA significantly improved the absolute number of CD4(+) and CD8(+) T cells (P< 0.01); while the proportion of CD4(+) to CD8(+) did not change (P >0.05). The numbers of CD4(+) and CD8(+) T cells in NSEA I group reached the peaks [(8.26+/-1.46) x 10(9)/L and (5.53+/-0.91) x 10(9)/L] at 72 hours. The absolute number of CD4(+) T cells in SEA I group reached the peak of (8.61+/-1.59) x 10(9)/L at 48 hours,and the absolute number of CD8(+) T cells reached the peak of (6.05+/-1.31) x 10(9)/L at 72 hours; both of them descended to normal level at 96 hours. The inhibition rates of SEA II group and NSEA II group were 58.9% and 50% and the percentages of life span increase were 167% and 169%, respectively. CONCLUSION:NSEA and SEA could induce the activation and proliferation of T cells in vivo but could not influence the proportion of CD4(+) and CD8(+) cells in the mice. The effects of NSEA were weaker but longer than that of SEA. This study demonstrated that NSEA has the sustained release effects and prolongs the effective time.

Effect of Staphylococcal Enterotoxin A on Cell Cycle Process and Apoptosis in Human Hepatoma SSMC7721 Cell

Antitumor Efficacy of Staphylococcal Enterotoxin A Liposomes in Vivo

Influence of Staphylococcal Enterotoxin A on Immunogenicity of Hepatocellular Carcinoma Cells

In Vitro Biological Activities of Transmembrane Superantigen Staphylococcal Enterotoxin A Fusion Protein

Inhibition on Liver Carcinoma Cells HepG2 by Se-methylselenocysteine

Antitumor effects of the fusion protein of transmembrane-staphylococcal enterotoxin A

[Influence of Nanoparticle-Encapsulated SEA on T-cell Subgroups and Its Antitumor Effect on Hepatoma].

Inhibitory effect of saikosaponins-d on human hepatocellular carcinoma cell line SMMC-7721 proliferation

Effects of Arsenic Acid on Proliferation, Apoptosis and Bcl-2 Expression of BEL-7402 Cells

Inhibition of Proliferation of 5-FU Combined with Thermotherapy in Human Hepatoma Cell Line

Influence of Salicylic Acid on Human Hepatic Cancer HepG2 Cells Growth In-vitro

Ganoderic acid A inhibits proliferation and invasion, and promotes apoptosis in human hepatocellular carcinoma cells

Staphylococcal Enterotoxin A Induces DNA Damage in Hepatocytes and Liver Tissues.

Effect of Litchi Seed Extract on Proliferation and Apoptosis of HepG-2 in Vitro

[Effect of Taspine Derivatives on Human Liver Cancer SMMC7721].

Antitumor efficacy of tumor infiltrating lymphocytes from hepatocellular carcinoma stimulated by staphylococcal enterotoxin A in vitro

Effect on Apoptosis、mitochondrial Membrane Potential and Ca 2+ Concentration in HepG-2 by CSEO

Antitumor Effects of Oxaliplatin on Human Hepatocellular Carcinoma SMMC7721 Cells in Vitro

Effect of HSP90 inhibitor on apoptosis in esophageal squamous carcinoma cell TE-1 and its mechanism

Effects of eicosapentaenoic acid on the growth of human cholangiocarcinoma cell lines FRH-0201

<i>In vivo</i>and<i>In Vitro</i>Antitumor Effects of a Staphylococcal Enterotoxin A Mutant (SEA-H61D)